# Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients

> **NCT03727399** · — · ENROLLING_BY_INVITATION · sponsor: **Mabylon AG** · enrollment: 300 (estimated)

## Conditions studied

- Pollen Allergy

## Interventions

- **OTHER:** blood withdrawal

## Key facts

- **NCT ID:** NCT03727399
- **Lead sponsor:** Mabylon AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2018-10-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03727399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03727399, "Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03727399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*